Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Ovarian Neoplasms 2Unresectable Stage III NSCLC 1Squamous Cell Carcinoma of Head and Neck 1Pharyngeal Neoplasms 1Paranasal Sinus Neoplasms 1Neoplasms, Unknown Primary 1Laryngeal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma 1Breast Neoplasms 1

Interventions

Cisplatin 22Radiotherapy 15Cetuximab 12Docetaxel 11Carboplatin 10pembrolizumab 8toripalimab 6camrelizumab 6Paclitaxel 5Nivolumab 5Neoadjuvant Therapy 5Fluorouracil 5Drug Therapy 5Chemoradiotherapy 5nimotuzumab 4durvalumab 4Blood Specimen Collection 4sintilimab 3cemiplimab 3apatinib 3advexin 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Immunohistochemistry 3Celecoxib 3nedaplatin 2Therapeutics 2Tegafur 2Radiotherapy, Intensity-Modulated 2Methotrexate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Squamous Cell Carcinoma of Head and Neck × CP protocol × Clear all
NCT05992610 2023-08-15

iCHRTL

Maria Sklodowska-Curie National Research Institute of Oncology

Phase NA Unknown
40 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡